Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Steven Fuller
Advertisement
Steven Fuller, PhD, is chief operating officer at Panacea Pharmaceuticals.
Articles by Steven Fuller
Advertisement
Latest Updated Articles
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
